Kedudukan dalam Saham
#31795
AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on... AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.
Harga Saham
$0.05234265
Disegerakkan terakhir: 2025-06-23
Perubahan (1 hari)
-3.01%
Perubahan (1 tahun)
0.00%
Perdagangan AroCell AB (publ) (AROC)
Harga AROC dengan permodalan pasaran b
Modal pasaran bagi AroCell AB (publ)(AROC)
Modal Pasaran: $12.06M
Sehingga August 2026, AroCell AB (publ) mempunyai modal pasaran sebanyak $12.06M. Ini menjadikan AroCell AB (publ) syarikat ke-31795th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran AroCell AB (publ) dari 2011 hingga 2026
AROC berbanding dengan 5 teratas yang paling popular stocks
| Harga AROC |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.460T
|
+45,283,296.54%
|
|
|
|
|
$4.489T
|
+37,233,211.71%
|
|
|
|
|
$4.141T
|
+34,342,174.50%
|
|
|
|
|
$3.569T
|
+29,595,356.28%
|
|
|
|
|
$2.798T
|
+23,205,215.77%
|
